Cargando…
The potential of activator protein 1 (AP-1) in cancer targeted therapy
Activator protein-1 (AP-1) is a transcription factor that consists of a diverse group of members including Jun, Fos, Maf, and ATF. AP-1 involves a number of processes such as proliferation, migration, and invasion in cells. Dysfunctional AP-1 activity is associated with cancer initiation, developmen...
Autores principales: | Song, Dandan, Lian, Yan, Zhang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361657/ https://www.ncbi.nlm.nih.gov/pubmed/37483616 http://dx.doi.org/10.3389/fimmu.2023.1224892 |
Ejemplares similares
-
EST12 regulates Myc expression and enhances anti-mycobacterial inflammatory response via RACK1-JNK-AP1-Myc immune pathway
por: Wu, Jian, et al.
Publicado: (2022) -
AP-1 confers resistance to anti-cancer therapy by activating XIAP
por: Wang, Yuan, et al.
Publicado: (2018) -
Endoplasmic reticulum stress promoted acinar cell necroptosis in acute pancreatitis through cathepsinB-mediated AP-1 activation
por: Han, Xiao, et al.
Publicado: (2022) -
Small Molecule Inhibitors
Targeting Activator Protein
1 (AP-1): Miniperspective
por: Ye, Na, et al.
Publicado: (2014) -
Host MKRN1-Mediated Mycobacterial PPE Protein Ubiquitination Suppresses Innate Immune Response
por: Dou, Yafeng, et al.
Publicado: (2022)